Ingredient Overages Are For Label Assurance, Not Potency Increase – FDA
This article was originally published in The Tan Sheet
Executive Summary
Dietary-supplement manufacturers should be prepared to demonstrate any overages are intended to ensure a product meets its label claim, not enhance the potency of the product, FDA officials say
You may also be interested in...
Supplement GMPs Stress Responsibility, Put Firms In Driver’s Seat For Testing
The dietary supplement good manufacturing practices final rule provides "a very flexible framework for required testing," said Vasilios H. Frankos, director of the dietary supplement programs division for FDA's Center for Food Safety and Applied Nutrition
OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study
Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers
OTC Prices Make PPI-Aspirin Therapy For CVD Cost-Effective – Study
Using proton pump inhibitors to prevent GI bleeding from low-dose aspirin therapy for cardiovascular health is cost-effective only at OTC prices, according to researchers